Single infusion of zoledronate in Paget’s disease of bone: a placebo-controlled, dose-ranging study-Reference-Cited by-同舟云学术

Single infusion of zoledronate in Paget’s disease of bone: a placebo-controlled, dose-ranging study

Published:1999-05 Issue:5 Volume:24 Page:81S-85S
ISSN:8756-3282
Container-title:Bone
language:en
Short-container-title:Bone

Author:

Buckler H,Fraser W,Hosking D,Ryan W,Maricic M.J,Singer F,Davie M,Fogelman I,Birbara C.A,Moses A.M,Lyles K,Selby P,Richardson P,Seaman J,Zelenakas K,Siris E

Publisher

Elsevier BV

Subject

Histology,Physiology,Endocrinology, Diabetes and Metabolism

Reference17 articles.

1. The acute phase response after bisphosphonate administration;Adami;Calcif Tissue Int,1987

2. Effects of two oral doses of alendronate in the treatment of Paget’s disease of bone;Adami;Bone,1994

3. Treatment of Paget’s disease of bone with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonate;Adami;Calcif Tissue Int,1986

4. Effects of intravenous pamidronate therapy on Paget’s disease of bone;Bombassei;J Med Sci,1994

5. Clinical review 39;Bone;J Clin Endocrinol Metabol,1992

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug treatment strategies for paget’s disease: relieving pain and preventing progression;Expert Opinion on Pharmacotherapy;2023-03-28

2. Bisphosphonates in the management of Paget's disease;Bone;2020-09

3. Bisphosphonates for Paget's disease of bone in adults;Cochrane Database of Systematic Reviews;2017-12-01

4. Effect of Zoledronic Acid on Rats’ Tissue SDF-1 Expression;International Journal of Hematology and Oncology;2016-12-30

5. Role of zoledronic acid in the prevention and treatment of osteoporosis;Clinical Interventions in Aging;2011-03